Bladder cancer typically occurs in adults age 55 or older. The average age at diagnosis is 73. Men are more likely to develop bladder cancer than women, and the disease is more prevalent in whites than in African Americans or Hispanic Americans.
With the addition of checkpoint inhibitor immunotherapy to the treatment armamentarium for advanced bladder cancer, the care landscape for urothelial carcinoma is evolving. Keep the entire multidisciplinary care team up-to-date with information and resources from the ACCC education program on Optimizing Outcomes for Urothelial Carcinoma in the Community Setting. Two options for participation: a live, virtual learning workshop or as a CME/CNE-eligible audio-guided web course.